FCX-007 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
36表皮水疱症1

36. 表皮水疱症


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02810951
(ClinicalTrials.gov)
July 1, 201613/6/2016A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)A Phase I/II Study of FCX-007 (Genetically-Modified Autologous Human Dermal Fibroblasts) for Recessive Dystrophic Epidermolysis Bullosa (RDEB)Epidermolysis Bullosa Dystrophica, RecessiveGenetic: FCX-007Castle Creek Biosciences, LLC.NULLTerminated7 YearsN/AAll6Phase 1/Phase 2United States